9th Nov 2011 16:19
RNS Number : 8130R
AGI Therapeutics plc
09 November 2011
AGI Therapeutics plc ('AGI')
Holding in Company
AGI was notified on the 9th November 2011 that Paul Johnson has increased his shareholding to 2,720,615 shares representing 4.04% of AGI's Issued share capital.
Contact Information
AGI Therapeutics
David G. Kelly, Chief Financial Officer Tel: +353 1 449 3254
This information is provided by RNS
The company news service from the London Stock Exchange
Related Shares:
Potentially Ai